MedTrace Logo

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

NCT06050850 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2025-10-24

No results posted yet for this study

Summary

The purpose of this study is to conduct a single arm pilot of the NOURISH-ALL (Nourishing Our Understanding of Role modeling to Improve Support and Health in Acute Lymphoblastic Leukemia) intervention focused on three components of participant engagement. This is a single arm intervention study that involves participation in a 6-session family intervention and three time points of multimethod data collection. The primary outcome is participant engagement, measured as recruitment, retention, and intended dose received.

This study will be conducted over 5 years in three phases:

* Aim 1a: Adapting the NOURISH-ALL Intervention for Families of Youth with ALL (Year 1)
* Aim 1b: Iteratively Refining the NOURISH-ALL Intervention (Year 2)
* Aim 2: Pilot Single-Arm Trial of NOURISH-ALL Focused on Participant Engagement (Years 3-5)

Conditions

  • ALL, Childhood
  • Behavior, Health

Interventions

BEHAVIORAL

NOURISH-ALL

Our NOURISH-ALL intervention will build on this existing NOURISH-T family based behavioral intervention with families of cancer survivors. The intervention, NOURISH-ALL, will adapt these family-based health promotion strategies to the early ALL treatment context.

Sponsors & Collaborators

  • Children's Mercy Hospital Kansas City

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Carolyn Bates, PhD · University of Kansas Medical Center

  • Keith August, MD · Children's Mercy Kansas City

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-17
Primary Completion
2028-10-01
Completion
2029-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06050850 on ClinicalTrials.gov